Forskningsoutput per år
Forskningsoutput per år
Forskningsoutput
- 31 resultat
Sökresultat
-
2024
SERPINH1 variants and thrombotic risk among middle-aged and older adults: a population-based cohort study
Manderstedt, E., Lind-Halldén, C., Halldén, C., Elf, J., Svensson, P. J., Engström, G., Melander, O., Baras, A., Lotta, L. A., Zöller, B. & Regeneron Genetics Center, 2024, I: Journal of Thrombosis and Haemostasis. 22, 3, s. 869-873 5 s.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2023
Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders
Olsson, A., Westesson, L. M., Baghaei, F., Holmström, M., Olsson, E., Magnusson, M., Ranta, S., Astermark, J., Andersson, N. G., Thanner, J., Szamosi, J., Daoura, L. & Sennfält, K., 2023, I: Haemophilia. 29, 1, s. 377-381Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2022
Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia
Xie, H., Ljung, R., Astermark, J. & Hylander, T., 2022 nov., I: Haemophilia. 28, 6, s. e259-e261Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Öppen tillgång -
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study
Manderstedt, E., Elf, J., Svensson, P. J., Engström, G., Melander, O., Zöller, B. & Regeneron Genetics Center, 2022, I: Research and practice in thrombosis and haemostasis. 6, 7, e12842.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Öppen tillgång -
2021
In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended-half-life FVIII products or not?
Berntorp, E., Krassova, S. & Aledort, L., 2021 nov. 1, I: Haemophilia. 27, 6, s. e762-e764Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Öppen tillgång -
Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study
Manderstedt, E., Halldén, C., Lind-Halldén, C., Elf, J., Svensson, P. J., Engström, G., Melander, O., Baras, A., Lotta, L. A., Zöller, B. & Regeneron Genetics Center, 2021 okt., I: Circulation. Genomic and precision medicine. 14, 5, e003449.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
Reactome Pathway Analysis of Venous Thromboembolism, Peripheral Artery Disease, Stroke, and Coronary Artery Disease
Zöller, B., Svensson, P. J., Huang, W. & Jianguang, J., 2021 juli 1, I: Thrombosis and Haemostasis. 121, 7, s. 964-966 3 s.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Öppen tillgång -
Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders
Holmström, M., Olsson, E., Astermark, J., Axelsson, M., Olsson, A., Myrin Westesson, L., Falk, A., Szamosi, J. & Sennfält, K., 2021, I: Haemophilia. 27, 4Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2018
Evaluation of prophylactic therapy in haemophilia with global coagulation tests
Zetterberg, E., Brolin, K., Lindahl, R., Knobe, K. & Berntorp, E., 2018 jan. 1, I: Haemophilia. 24, 1, s. e10-e13Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2015
Acute effects of exercise on specific and global coagulation parameters in severe haemophilia A.
Olofsson, H. E., Lövdahl, S., Thorsson, O., Berntorp, E. & Zetterberg, E., 2015, I: Haemophilia. 21, 5, s. E416-E419Forskningsoutput: Tidskriftsbidrag › Letter
-
Bleeding phenotype in carriers of haemophilia A does not correlate with thrombin generation
Olsson, A., Hellgren, M., Berntorp, E., Holmstrom, M. & Baghaei, F., 2015, I: Haemophilia. 21, 1, s. E111-E113Forskningsoutput: Tidskriftsbidrag › Letter
-
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
Berntorp, E. & Iorio, A., 2015, I: Blood. 125, 24, s. 3816-3817Forskningsoutput: Tidskriftsbidrag › Letter
-
2014
A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
Berntorp, E., Shapiro, A. D., Waters, J. & Astermark, J., 2014, I: Haemophilia. 20, 5, s. e362-e364Forskningsoutput: Tidskriftsbidrag › Letter
-
Clinically relevant non-neutralizing anti-FVIII antibodies in a hemophiliac
Klintman, J., Hillarp, A., Berntorp, E. & Astermark, J., 2014, I: International Monitor on Hemophilia. 22, s. 19–21Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
The association between red cell distribution width and venous thromboembolism: A biochemical evaluation
Zöller, B., Melander, O., Svensson, P. & Engström, G., 2014, I: Thrombosis Research. 133, 6, s. 1164-1165Forskningsoutput: Tidskriftsbidrag › Letter
-
2013
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
Bergman, E., Smith, G., Wieloch, M., Braun, O., Svensson, P. & vanderPals, J., 2013, I: Thrombosis Research. 132, 2, s. 316-317Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2012
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
Hermans, C., Astermark, J. & De Moerloos, P., 2012, I: Journal of Thrombosis and Haemostasis. 10, 10, s. 2194-2196Forskningsoutput: Tidskriftsbidrag › Letter
-
The international factor IX treatment network survey.
Berntorp, E., Shapiro, A. D., Waters, J. & Astermark, J., 2012, I: Haemophilia. 18, 3, s. e60-e62Forskningsoutput: Tidskriftsbidrag › Letter
-
2011
Thrombotic occlusion of all left coronary branches in a young woman with severe ulcerative colitis
Gustavsson, C. G., Svensson, P., Hertervig, E., Lennart, S., Peter, H., Natascia, M.-L. & Olsson, S.-E., 2011, I: ISRN Cardiology. 134631.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Öppen tillgång -
2008
Patients' and their family members' understanding of the genetics of type 1 von Willebrand disease.
Lanke, E., Lanke, J. & Lethagen, S., 2008, I: Haemophilia. 14, 5, s. 1127-1130Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
Variability of clinical manifestations of factor VII-deficiency in subjects homozygous or heterozygous for the F7 gene mutation A294V
Herrmann, F. H., Wulff, K., Strey, R., Siegemund, A., Astermark, J. & Schulman, S., 2008, I: Haematologica. 93, 8, s. 1273-1275Forskningsoutput: Tidskriftsbidrag › Letter
-
2007
Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate((R)) P/Humate-P((R))) in von Willebrand Disease and Haemophilia A: A Viewpoint by Eric Berntorp.
Berntorp, E., 2007, I: Drugs. 67, 10, s. 1520-1520Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2005
APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
Strandberg, K., Stenflo, J., Nilsson, C. & Svensson, P., 2005, I: Journal of Thrombosis and Haemostasis. 3, 11, s. 2578-2580Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Fil188 Nedladdningar (Pure) -
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
Berntorp, E., Astermark, J., Donfield, S. M., Nelson, G. W., Oldenburg, J., Shapiro, A. D., Dimichele, D. M., Ewenstein, B. M., Gomperts, E. D. & Winkler, C. A., 2005, I: Haemophilia. 11, 4, s. 427-429Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp, E., Astermark, J., Björkman, S., Blanchette, V. S., Fischer, K., Giangrande, P. L. F., Gringeri, A., Ljung, R., Manco-Johnson, M. J., Morfini, M., Kilcoyne, R. F., Petrini, P., Rodriguez-Merchan, E. C., Schramm, W., Shapiro, A., M Van Den Berg, H. & Hart, C., 2003, I: Haemophilia. 9, Suppl 1, s. 41278Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Fil441 Nedladdningar (Pure) -
2001
No increased risk of venous thrombosis in women taking tranexamic acid
Berntorp, E., Follrud, C. & Lethagen, S., 2001, I: Thrombosis and Haemostasis. 86, 2, s. 714-715Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
1998
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
Zöller, B., Svensson, P. J., Dahlbäck, B. & Hillarp, A., 1998 mars 15, I: Blood. 91, 6, s. 2210-1Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
Zöller, B., Svensson, P. J., Dahlbäck, B. & Hillarp, A., 1998 mars 15, I: Blood. 91, 6, s. 2210-2211 2 s.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
Öppen tillgång -
1994
Myocardial infarction associated with homozygous resistance to activated protein C
Holm, J., Zöller, B., Svensson, P. J., Berntorp, E., Erhardt, L. & Dahlbäck, B., 1994 nov. 7, I: The Lancet. 344, 8927, s. 952-953 2 s.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
1992
Factor VIII and factor IX inhibitors in haemophiliacs
Ljung, R., Petrini, P., Lindgren, A. C., Tengborn, L. & Nilsson, I. M., 1992 juni 20, I: The Lancet. 339, 8808, s. 1550-1551 2 s.Forskningsoutput: Tidskriftsbidrag › Letter › Peer review
-
1990
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate
Berntorp, E., Nilsson, I. M., Ljung, R. & Widell, A., 1990, I: The Lancet. 335, 8704, s. 1531Forskningsoutput: Tidskriftsbidrag › Letter › Peer review